Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 321

Results For "IMI"

3566 News Found

Algorithm to calculate number of years one lives with good health
Healthcare | October 12, 2021

Algorithm to calculate number of years one lives with good health

In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks


Everest Organics develops API for molnupiravir
News | October 12, 2021

Everest Organics develops API for molnupiravir

The drug is being developed at lab scale for the first-line of treatment of Covid-19


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


Glenmark launches Tavulus for COPD treatment in Spain
Drug Approval | October 11, 2021

Glenmark launches Tavulus for COPD treatment in Spain

It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK


Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials
Biotech | October 11, 2021

Deep Lens and Pacific Cancer Centre collaborate to improve clinical trials

VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials


HealthEdge opens its facility in Pune
Healthcare | October 11, 2021

HealthEdge opens its facility in Pune

The Pune centre expands its presence beyond Bangalore and Hyderabad


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation
Biotech | October 09, 2021

Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation

Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022


Govt clarifies on export ban of syringes
News | October 09, 2021

Govt clarifies on export ban of syringes

Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme


Sanofi says positive results from flu vaccine with mRNA booster study
Biotech | October 08, 2021

Sanofi says positive results from flu vaccine with mRNA booster study

The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older